Gamma interferon inhibits production of anti-OspA borreliacidal antibody in vitro

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 5, 2002, Pages 1095-1101

  Munson, Erik L ^a   Du Chateau, Brian K ^a   Jensen, Jani R ^a   Callister, Steven M ^a   DeCoster, David J ^a   Schell, Ronald F ^a  

^a WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CYTOKINE; OSPA ANTIBODY; RECOMBINANT GAMMA INTERFERON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFECTION PREVENTION; LYME DISEASE; LYMPH NODE CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; CELLS, CULTURED; FLOW CYTOMETRY; INTERFERON TYPE II; LIPOPROTEINS; LYME DISEASE; LYME DISEASE VACCINES; LYMPH NODES; MACROPHAGES; MICE; MICE, INBRED C3H; RECOMBINANT PROTEINS;

EID: 0036731880     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.5.1095-1101.2002     Document Type: Article

References (43)

1. Nitric oxide suppresses human T lymphocyte proliferation through IFN-γ-dependent and IFN-γ-independent induction of apoptosis
2. Borrelia burgdorferi antigens that are targets of antibody-dependent, complement-mediated killing in the rhesus monkey
3. Isolation and cultivation of Lyme disease spirochetes
4. Role of interferons and other cytokines in the regulation of the immune response
5. Cellular responses to interferon-γ
6. Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect B. burgdorferi
7. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis
8. Lyme disease assay which detects killed Borrelia burgdorferi
9. Affinity purification peptide analysis and cDNA sequence of the mouse interferon γ receptor
10. The antibody response in Lyme disease: Evaluation of diagnostic tests
11. Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi
12. Western blotting in the serodiagnosis of Lyme disease
13. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA
14. T-cell-mediated immune regulation; help and suppression
15. IFN-gamma abrogates IL-7-dependent proliferation in pre-B cells, coinciding with onset of apoptosis
16. Interferon-gamma arrests proliferation and causes apoptosis in stromal cell/interleukin-7-dependent normal murine pre-B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobulin-positive B cells
17. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
18. Characterization and use of monoclonal and polyclonal antibodies against the mouse interferon-γ receptor
19. Development of severe destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi
20. + T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters
21. Interferon gamma plays a critical role in induced cell death of effector T cell: A possible third mechanism of self tolerance
22. Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi Zentbl
23. Production of OspA-borreliacidal antibody in vitro and effects of interleukin-4
24. Environmental signals influencing expression of the IFN-γ receptor on human T cells control whether IFN-γ promotes proliferation or apoptosis
25. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine
26. Interleukin-4 and interferon-γ: The quintessence of a mutual antagonistic relationship
27. B-cell stimulating factor-1/interleukin 4
28. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen
29. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi
30. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in presence of complement
31. Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferi
32. Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters
33. The 39 kilodalton protein of Borrelia burgdorferi: A target for bactericidal human monoclonal antibodies
34. A vaccine consisting of recombinant Borrelia burgdorferi outer surface protein A to prevent Lyme disease
35. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochaetal infection in mice
36. Immunoglobulin class switching
37. The spirochetal etiology of Lyme disease
38. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant
39. Sera from OspA-vaccinated dogs, but not from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi
40. Inhibition of B cell receptor-mediated apoptosis by IFN
41. Alternative vaccination schedules (0, 1, and 6 months versus 0, 1, and 12 months) for a recombinant OspA Lyme disease vaccine
42. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin